Andrew Stephens is the Chief Scientific Officer at Cleo Diagnostics, where they develop groundbreaking diagnostic technologies aimed at improving women's healthcare. With over 20 years of experience in molecular and cellular biology research, they are dedicated to translating scientific innovations into healthcare advancements. Andrew has an extensive publication record and holds multiple patents related to cancer diagnosis and treatment. They currently serve as the Acting CEO of AMTBio Pty Ltd, collaborating with a talented team to advance innovative cancer therapeutics from proof of concept to phase I clinical trials. Andrew's academic journey continues at Monash University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices